about
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also ge...
Read More
192.44
4.03
(2.14%)
163.1K
XNAS Volume
XNAS 11 Mar, 2026 11:12 AM (EDT)
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks
View Similar
Embed DVM
Biogen Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..